The combined supplementation of the botanical berberine and probiotics has been found to help reduce blood sugar levels in diabetic patients, more so than taking each product alone, says a 12-week RCT conducted in China.
Galmed Pharmaceuticals and MyBiotics Pharma are to join forces in a R&D collaboration looking into how the microbiome responds to a compound used to treat non-alcoholic steatohepatitis (NASH).
The gut-brain axis is a hot topic amongst scientists, doctors, and dietary supplement businesses today, but this was not the case just five years ago, where the idea of using probiotics to address mental and cognitive health issues was met with much scepticism.
Consumption of Yakult’s synbiotic drink MPR03 daily for three weeks could improve bowel movement and alter the intestinal microbial composition in elderly Korean women.
A DuPont review has reinforced the link between the gut microbiome and sporting performance as the firm’s researchers identify probiotics’ role in training support, performance, and post-exercise recovery.
Tackling allergies, improving digestion and aiding immunity are the key pillars for infant nutrition product innovation, says a group of expert panellists from major brand names such as Biostime, Morinaga, and Nuchev.
Scientists in the US think certain gut bacteria may offer protection against damage done by radiation used in cancer treatment as the study also notes improved recovery of blood cell production.
Interest in the gut microbiome’s role in weight, mental health and immunity will become a global trend in 2021, according to ADM, who point to the current pandemic as fuelling consumer awareness.
ProDigest and Biofortis are to enter into an agreement to strengthen and enlarge their service offerings that currently includes microbiome research and probiotic and botanical extract efficacy.
A study done on premature infants gives a picture of how probiotics can beneficially shift the microbiomes of this vulnerable population. It adds to the body of research backing the use of probiotics to assist in the safe development of a healthy digestive...
Microbiome therapeutics firm MyBiotics Pharma have received €2m ($2.3m) in funding by the European Union (EU) to develop technology capable of delivering personalised probiotics to tackle gut-related diseases.
US ingredient giants ADM are to expand its microbiome-related production activities five-fold with the creation of a European facility that is expected to be in operation in 2022.
